Bank of New York Mellon’s CARGO Therapeutics CRGX Stock Holding History

Bank of New York Mellon’s Portfolio CRGX Stock Details CRGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-104,716	Closed	-$431K	–	4189
2025 Q2	$431K	Buy	104,716 +9,187	+10%	+$39.4K	﹤0.01%	3591
2025 Q1	$389K	Buy	95,529 +6,893	+8%	+$46.2K	﹤0.01%	3575
2024 Q4	$1.28M	Sell	88,636 -1,074	-1%	-$19.5K	﹤0.01%	3003
2024 Q3	$1.66M	Buy	89,710 +20,539	+30%	+$367K	﹤0.01%	2846
2024 Q2	$1.14M	Buy	69,171 +7,146	+12%	+$136K	﹤0.01%	3118
2024 Q1	$1.38M	Buy	62,025 +44,958	+263%	+$1.07M	﹤0.01%	2973
2023 Q4	$395K	Buy	+17,067	New	+$289K	﹤0.01%	3681

Other funds holding CRGX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Bank of New York Mellon's CRGX Position: Q3 2025 in Review

Bank of New York Mellon sold out of CARGO Therapeutics (CRGX) in Q3 2025, closing a stake of 104,716 shares — an estimated $431K sold.

Bank of New York Mellon first reported a position in CRGX in Q4 2023 and held it in 7 quarters. The position peaked at $1.66M in Q3 2024. 1 fund tracked by Wall St. Rank holds CRGX as of Q3 2025.

Bank of New York Mellon reported no remaining CARGO Therapeutics position as of Q3 2025 after selling out during the quarter.
Bank of New York Mellon sold 104,716 CARGO Therapeutics shares in Q3 2025, an estimated $431K.
Bank of New York Mellon first reported a position in CARGO Therapeutics in Q4 2023 and held it in 7 quarters.
Bank of New York Mellon's CARGO Therapeutics position peaked at $1.66M in Q3 2024.
1 fund tracked by Wall St. Rank held CARGO Therapeutics as of Q3 2025.

Based on Bank of New York Mellon's 13F filing for Q3 2025, filed 3 Nov 2025.